Preventive healthtech startup Cent has raised $15 million (approximately ₹143 crore) in a Series A funding round to scale its artificial intelligence-driven diagnostic platform and clinical research infrastructure, according to reporting by Inc42. Alongside the financing, the company announced the acquisition of Medsee, an AI-powered radiology reporting workflow platform.
The investment round was co-led by venture capital firm Blume Ventures and early-stage investor South Park Commons, with participation from prominent angel investors including former Vodafone chief executive Arun Sarin and former OpenAI B2B chief technology officer Srinivas Narayanan.
Leadership and Capital Deployment
Cent was founded earlier this year by Practo co-founder Shashank ND, former Ola Electric chief marketing officer Anshul Khandelwal, and former Lenskart product head Arpit Garg. The startup previously secured $5 million in a seed round backed by South Park Commons and OneFlow Holdings.
Management stated that the fresh capital will be deployed to strengthen research and development while expanding the company's AI, engineering, and clinical teams. Integrating Medsee is intended to standardize and accelerate radiology reporting workflows, allowing radiologists to process higher scan volumes with consistent reporting accuracy.
| Metric / Detail | Cent Verification Milestone |
|---|---|
| Funding Raised | $15 Million (approx. ₹143 Crore) |
| Funding Stage | Series A |
| Lead Investors | Blume Ventures, South Park Commons |
| Notable Angels | Arun Sarin (ex-Vodafone CEO), Srinivas Narayanan (ex-OpenAI B2B CTO) |
| Strategic M&A | Acquisition of radiology workflow platform Medsee |
| Flagship Offering | Cent Check (comprehensive 2-hour scan screening) |
| Screening Price | ₹27,500 |
Clinical Model and Technology Architecture
Cent operates on a mission to extend healthy human lifespans by screening asymptomatic individuals for more than 300 clinical conditions, including early-stage cardiovascular diseases, cancers, and neurological disorders.
Its primary diagnostic package, named Cent Check, aggregates a full-body MRI, low-dose CT, DEXA scan, electrocardiogram (ECG), and echocardiography into a single testing session lasting roughly two hours. Priced at ₹27,500, the service positions itself against standard diagnostic checkups that depend heavily on routine blood biochemistry and basic ultrasounds.
The company evaluates patient risk through its proprietary CCNM protocol, which evaluates cancer, cardiac, neurological, and metabolic indicators. Cent's AI engine consolidates data across these imaging modalities to generate organ-specific risk assessments while shortening acquisition times for MRI sequences, aiming to catch chronic pathologies before clinical symptoms emerge.
Frequently Asked Questions
Who led Cent's $15 million funding round?
The Series A round was co-led by Blume Ventures and South Park Commons, with participation from angel investors such as former Vodafone CEO Arun Sarin and former OpenAI B2B CTO Srinivas Narayanan.
What is Cent and who founded it?
Cent is an AI-powered preventive healthcare startup founded by Practo co-founder Shashank ND, former Ola Electric CMO Anshul Khandelwal, and former Lenskart product executive Arpit Garg.
Why did Cent acquire Medsee?
Cent acquired Medsee, an AI radiology workflow startup, to automate and accelerate reporting times for medical imaging as patient scan volume scales up.
What does the Cent Check diagnostic protocol include?
Cent Check consolidates full-body MRI, low-dose CT, DEXA scans, ECG, and echocardiography into a single two-hour assessment priced at ₹27,500, screening for more than 300 asymptomatic health conditions.
